|
|
|
|
||
Hold
Re reading the Patent, at least the first 10 pages.I was curious as to whether the Dystrophin gene was in the realm of future or maybe present interesdt to SGMO. Clearly6 it is. Much is being made of other drugs targeting DMD. Now my next question. Can the IVPRP be used to deliver the Dystrophin protein to where it is needed? How much would that drug or "functional cure" be worth. Not an annuity treatment as is what every other drug I have read about propose to do, but a ONE TIME introduction to the albumine gene. May be possible to highjack small amounts of albumine until a curative level is reached. This would be or could be assessed patient by patient. But no body reads patents. "B" |
return to message board, top of board |
Msg # | Subject | Author | Recs | Date Posted |
71745 | Re: Re reading the Patent, at least the first 10 pages. | zincfinger | 7 | 3/1/2015 7:00:46 PM |